S
Saeid Najafi Fard
Publications - 11
Citations - 321
Saeid Najafi Fard is an academic researcher. The author has contributed to research in topics: Vaccination & Pneumonia. The author has an hindex of 5, co-authored 11 publications receiving 133 citations.
Papers
More filters
Journal ArticleDOI
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
Linda Petrone,Elisa Petruccioli,Valentina Vanini,Gilda Cuzzi,Saeid Najafi Fard,Tonino Alonzi,Concetta Castilletti,Fabrizio Palmieri,Gina Gualano,Pietro Vittozzi,Emanuele Nicastri,Luciana Lepore,Andrea Antinori,Alessandra Vergori,Nadia Caccamo,Fabrizio Cantini,Enrico Girardi,Giuseppe Ippolito,Alba Grifoni,Delia Goletti +19 more
TL;DR: Immune response to SARS-CoV-2 peptides in a whole-blood assay is associated to COVID-19 and it is characterized by both Th1 and Th2 profile, which may be useful for developing new T-cell based diagnostic tests for disease and vaccine settings.
Journal ArticleDOI
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Catherine W.M. Ong,Giovanni Battista Migliori,Mario C. Raviglione,Mario C. Raviglione,Gavin Macgregor-Skinner,Giovanni Sotgiu,Jan-Willem C. Alffenaar,Simon Tiberi,Simon Tiberi,Cornelia Adlhoch,Tonino Alonzi,Sophia Archuleta,Sergio Brusin,Emmanuelle Cambau,Maria Rosaria Capobianchi,Concetta Castilletti,Rosella Centis,Daniela Maria Cirillo,Lia D'Ambrosio,Giovanni Delogu,Susanna Esposito,Jose Figueroa,Jon S. Friedland,Benjamin Choon Heng Ho,Giuseppe Ippolito,Mateja Janković,Hannah Yejin Kim,Hannah Yejin Kim,Hannah Yejin Kim,Senia Rosales Klintz,Csaba Ködmön,Eleonora Lalle,Yee Sin Leo,Chi Chiu Leung,Anne-Grete Märtson,Mario Melazzini,Saeid Najafi Fard,Pasi Penttinen,Linda Petrone,Elisa Petruccioli,Emanuele Pontali,Laura Saderi,Miguel Santin,Miguel Santin,Antonio Spanevello,Reinout van Crevel,Marieke J. van der Werf,Dina Visca,Miguel Viveiros,Jean-Pierre Zellweger,Alimuddin Zumla,Delia Goletti +51 more
TL;DR: The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety).
Journal ArticleDOI
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.
Linda Petrone,Elisa Petruccioli,Tonino Alonzi,Valentina Vanini,Gilda Cuzzi,Saeid Najafi Fard,Concetta Castilletti,Fabrizio Palmieri,Gina Gualano,Pietro Vittozzi,Emanuele Nicastri,Luciana Lepore,Alba Grifoni,Andrea Antinori,Alessandra Vergori,Giuseppe Ippolito,Fabrizio Cantini,Delia Goletti +17 more
TL;DR: In this article, the effect of baricitinib on the SARS-CoV-2-specific response using the whole-blood platform was investigated. And the results showed that exogenous addition of this therapy significantly decreased IFN-γ response to spike.
Journal ArticleDOI
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
Alessandra Aiello,Saeid Najafi Fard,Elisa Petruccioli,Linda Petrone,Valentina Vanini,Chiara Farroni,Gilda Cuzzi,Assunta Navarra,Gina Gualano,Silvia Mosti,Luca Pierelli,Emanuele Nicastri,Delia Goletti +12 more
TL;DR: In this paper, the best peptide pool was identified to detect SARS-CoV-2-specific T cell response using a whole-blood platform and ELISA was used to analyse interferon (IFN)-γ levels.
Journal ArticleDOI
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.
Maria Musso,Francesco Di Gennaro,Gina Gualano,Silvia Mosti,Carlotta Cerva,Saeid Najafi Fard,Raffaella Libertone,Virginia Di Bari,Massimo Cristofaro,Roberto Tonnarini,Concetta Castilletti,Delia Goletti,Fabrizio Palmieri +12 more
TL;DR: In this article, a case of a patient with in vitro immune cell anergy affected by bilateral cavitary pulmonary TB and subsequent COVID-19-associated pneumonia with a worst outcome was described from both the clinical and immunological point of view.